Month: December 2020

FTI Consulting Bolsters Health Solutions Practice with Seven Senior Appointments

Written by Customer Service on December 10, 2020. Posted in Public Companies.

WASHINGTON, Dec. 10, 2020 (GLOBE NEWSWIRE) — FTI Consulting, Inc. (NYSE: FCN) today announced the appointment of seven professionals to its Health Solutions practice, including Senior Managing Directors James Fisher, Julie Kliger and Kevin McCadden, and Managing Directors Matthew Leshy, Juliana Malhotra, Patterson Shafer and Amy Showalter.“We are pleased to continue executing on our strategy and commitment to growing our Health Solutions business, and we are excited to welcome these key members to our team” said Charles Overstreet, Global Leader of the Health Solutions practice at FTI Consulting. “Jim, Julie, Kevin, Matt, Juliana, Pat and Amy bring deep industry expertise, know our clients’ businesses and enhance our ability to help them navigate through these turbulent times.”Based in Brentwood, Tenn., Mr. Fisher is a seasoned...

Arbutus Announces Robust HBsAg Decline Data with AB-729 Dosed at 60 mg Every 8 Weeks in Chronic Hepatitis B Subjects

Written by Customer Service on December 10, 2020. Posted in Public Companies.

Repeat dosing of 60 mg AB-729 every 8 weeks resulted in mean HBsAg declines of –1.37 log10 (N=6) comparable to AB-729 dosed every 4 weeks (–1.44 log10, N=7, p

Bellicum Enrolls First Patient in Phase 1/2 Clinical Trial for BPX-603

Written by Customer Service on December 10, 2020. Posted in Public Companies.

HOUSTON, Dec. 10, 2020 (GLOBE NEWSWIRE) — Bellicum Pharmaceuticals, Inc. (NASDAQ:BLCM), a leader in developing novel, controllable cellular immunotherapies for cancers, today announced enrollment and apheresis of the first patient in the Phase 1/2 clinical trial for BPX-603 in patients with tumors that express human epidermal growth factor 2 (HER2). BPX-603 is Bellicum’s first dual switch GoCAR-T® product candidate that incorporates the company’s iMC activation and CaspaCIDe® safety switch technologies.“Initiation of this Phase 1/2 dose escalation clinical trial for BPX-603 denotes an important achievement for Bellicum and represents our second GoCAR-T program to enter the clinic,” stated Rick Fair, President and CEO. “This program may provide further validation of our technology’s ability to enhance both the efficacy and safety...

Hofseth Biocare ASA: TRANSFER OF LISTING FROM EURONEXT EXPAND TO OSLO BØRS

Written by Customer Service on December 10, 2020. Posted in Public Companies.

As announced on 9 December 2020, the Oslo Stock Exchange has approved the application from Hofseth BioCare ASA (the “Company”) for transfer of its listing from Euronext Expand (previously Oslo Axess) to Oslo Børs.The first day of trading of the Company’s shares on Oslo Børs will be on 14 December 2020. Consequently, the last day of trading of the Company’s shares on Euronext Expand will be tomorrow, 11 December 2020. The ticker and ISIN of the Company’s shares will remain unchanged.The Company has prepared a prospectus dated 3 December 2020 (the “Prospectus”) in connection with, inter alia, the transfer of listing, and such prospectus was published on 4 December 2020. The Prospectus is, subject to applicable securities laws, available at www.paretosec.com/updates/transactions. The Prospectus is...

VA San Diego Healthcare System Joins the Phase II Trial of LSALT Peptide for the Treatment of Complications in Hospitalized COVID-19 Patients

Written by Customer Service on December 10, 2020. Posted in Public Companies.

TORONTO, Dec. 10, 2020 (GLOBE NEWSWIRE) — Arch Biopartners Inc. (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF), announced today that the Veterans Affairs San Diego Healthcare System (VASDHS) has started recruiting patients for the Phase II trial of its lead drug LSALT peptide, targeting the prevention of acute lung injury, acute kidney injury and other complications caused by inflammation in hospitalized patients with moderate to severe cases of COVID-19.“Acute lung injury and acute kidney injury are among the most serious consequences of COVID-19, and novel medications focused on preventing these organ failures have the potential to be life-saving. We are excited to be part of this research, and to give our Veterans the opportunity to participate in this trial,” said Dr. Mark Hepokoski, M.D. a pulmonary and critical...

Point of Care Diagnostics Market to Exhibit a Decent CAGR of 7.3% and Hit USD 23.36 Billion by 2027; Increasing Cases of Acute Diseases to Spur Sales Opportunities, states Fortune Business Insights™

Written by Customer Service on December 10, 2020. Posted in Mergers And Acquisitions.

Pune, India, Dec. 10, 2020 (GLOBE NEWSWIRE) — The global Point of Care Diagnostics Market size is expected to reach USD 23.36 billion by 2027, exhibiting a CAGR of 7.3% during the forecast period. The market size stood at USD 18.45 billion in 2019. The growing acceptance of POC testing kits in the treatment of acute and chronic diseases will spur ruminative opportunities for the global market, states Fortune Business Insights, in a report. The market size in North America stood at USD 6.65 billion in 2019. The growth in the region is attributed to the increasing adoption of advanced point of care diagnostics solutions for the detection of various infectious diseases.KEY INDUSTRY DEVELOPMENTS:June 2020 – Cepheid announced the development of Xpert Xpress SARS-CoV-2/Flu/RSV a four-in-one combination test used for the detection...

Lee Enterprises posts strong quarter and fiscal year results

Written by Customer Service on December 10, 2020. Posted in Earnings Releases And Operating Results.

Revenue trends improved 7.8 percentage points compared to third quarterSubscription revenue totaled 46.5% of total operating revenue2020 Debt reduction totaled $37.7 million since March refinancingImplemented $84 million in Cost Synergies in 2020DAVENPORT, Iowa, Dec. 10, 2020 (GLOBE NEWSWIRE) — Lee Enterprises, Incorporated (NYSE: LEE), a leading provider of high quality, trusted, local news, information and a major digital and subscription platform in 77 markets, today reported fourth quarter and year-to-date financial results(1) for the period ended September 27, 2020.Financial Highlights(2):Fourth Quarter Highlights(1):Total digital revenue, including digital advertising, digital subscription revenue and digital services, was $47.9 million and represented 25% of our operating revenue.Revenue at TownNews increased 7.0% in the...

Whitestone Declares First Quarter 2021 Dividends, Provides a Business Update Related to COVID-19 Rental Collections and Liquidity Borrowings

Written by Customer Service on December 10, 2020. Posted in Dividend Reports And Estimates.

HOUSTON, Dec. 10, 2020 (GLOBE NEWSWIRE) — Whitestone REIT (NYSE: WSR) (“Whitestone” or the “Company”), a leading owner and operator of open-air, e-commerce resistant, lifestyle community-centered retail properties located in the largest, fastest-growing and most affluent Texas and Arizona markets in the Sunbelt, provides a business update regarding the dividend for the first quarter of 2021, liquidity borrowings, and rental collections for the month of November.Dividend AnnouncementWhitestone REIT’s Board of Trustees has declared a monthly cash dividend of $0.035 per share on the Company’s common shares and operating partnership units. The dividend amount of $0.035 per share represents a quarterly amount of $0.105, and an annualized amount of $0.42 per share. The first quarter dividend distribution for 2021 will be as detailed below:Full...

Skylight Health to Add 16th State with Acquisition of Florida Clinic Group with $5 million in Revenue and $1.2 million EBITDA

Written by Customer Service on December 10, 2020. Posted in Mergers And Acquisitions.

Florida based primary and urgent care clinic group is an established medical practice.In 2019, the clinic generated CAD 5 million in revenues and CAD 1.2 in EBITDA.Skylight Health’s forecasted annual run rate to now be over CAD 25 million combined with the completion of the previous five announced transactions.Total consideration value of CAD 4.8 million (50% cash, 50% shares) for the acquisition representing a 4x EBITDA multiple.This transaction will be immediately accretive to the Company adding experienced management, new complementary services and expansion of services to existing US markets.TORONTO, Dec. 10, 2020 (GLOBE NEWSWIRE) — Skylight Health Group Inc (CSE:SHG; OTCQX: SHGFF) (“SHG” or the “Company”), one of the largest multi-specialty healthcare systems in the United States, is pleased to announce that it has entered...

Minerals Technologies Statement Regarding Elementis plc (“Elementis” or “the Company”)

Written by Customer Service on December 10, 2020. Posted in Mergers And Acquisitions.

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION.THIS IS AN ANNOUNCEMENT FALLING UNDER RULE 2.8 OF THE CITY CODE ON TAKEOVERS AND MERGERS (THE “CODE”).THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION.NEW YORK, Dec. 10, 2020 (GLOBE NEWSWIRE) — Further to the decision by the Elementis Board to reject our increased all-cash possible offer for the Company of 130 pence per Elementis share, Minerals Technologies Inc. (NYSE: MTX) (“MTI”) announces today that it does not intend to make an offer for Elementis under Rule 2.7 of the Code.Minerals Technologies believes that its all-cash proposal of 130 pence per share was fair, based on information in the public...

Month: December 2020

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals